NexImmune Inc.

0.00
-0.00 (-100.00%)
At close: Apr 04, 2025, 11:37 AM
-100.00%
Bid n/a
Market Cap 139
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -18.51
PE Ratio (ttm) n/a
Forward PE -0.03
Analyst n/a
Ask n/a
Volume 60
Avg. Volume (20D) 2,682
Open 0.00
Previous Close 0.00
Day's Range 0.00 - 0.00
52-Week Range 0.00 - 7.05
Beta 2.02

About NEXI

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 12, 2021
Employees 6
Stock Exchange OTC
Ticker Symbol NEXI
Full Company Profile